Experimental Malaria Vaccine Provides Durable Protection Against Multiple Strains in NIH Clinical Trial

An experimental malaria vaccine protected healthy subjects from infection with a malaria strain different from that contained in the vaccine, according to a study published this week in the Proceedings of the National Academy of Sciences (PNAS). The research was conducted by scientists at the University of Maryland School of Medicine and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Source: University of Maryland School of Medicine News Headlines - Category: Universities & Medical Training Source Type: news